46ad74b00d
- Source: inbox/queue/2026-02-18-medrxiv-oregon-psilocybin-services-mental-health-outcomes.md - Domain: health - Claims: 0, Entities: 2 - Enrichments: 3 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
1.6 KiB
Bendable Therapy
Type: Psilocybin service center
Location: Portland, Oregon
Status: Operating under Oregon Measure 109
Domain: Psychedelic-assisted therapy
Overview
Bendable Therapy is a psilocybin service center operating under Oregon's Measure 109 state-regulated psilocybin program. The center is notable for exceeding Oregon's minimum regulatory requirements by providing enhanced screening, multiple preparation sessions, and structured integration support.
Research
Bendable Therapy conducted the first published outcomes study from Oregon's Measure 109 program, a prospective naturalistic study from March 2024 to April 2025. The study enrolled 91 clients with 88 completing all components, demonstrating large effect sizes for depression (d=0.90), anxiety (d=1.04), and wellbeing (d=2.14) at 30-day follow-up.
Service Model
- Average dose: 27.8 mg Total Psilocybin Equivalents
- Session format: 56.8% individual, 43.2% group
- Integration: 80% client attendance rate
- Enhanced protocol beyond Oregon minimum requirements
Client Demographics
The center's client base reflects significant demographic disparities:
- 87.5% white (vs. Oregon general population)
- 84.1% completed higher education
- 77.3% earning above $50K annually
- 46.6% traveling from out of state
- 64.8% with prior psilocybin experience
- Median age 43 years
Timeline
- 2024-03 — Began prospective naturalistic outcomes study
- 2025-04 — Completed data collection for first Oregon Measure 109 outcomes study
- 2026-02-18 — Published medRxiv preprint showing large effect sizes but significant demographic disparities in access